Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-12
2006-12-12
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S438000, C514S471000, C514S617000, C544S393000, C548S557000, C349S074000, C349S045000, C349S045000, C564S139000
Reexamination Certificate
active
07148225
ABSTRACT:
Substituted biaryl amides of Formula I are provided. Such compounds are ligands that may be used to modulate C5a receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological C5a receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies
REFERENCES:
patent: 2149279 (1939-03-01), Dalmer et al.
patent: 2965646 (1960-12-01), Gardner et al.
patent: 6723743 (2004-04-01), Thurkauf et al.
patent: 2004/0014782 (2004-01-01), Krause
patent: 0127727 (1984-02-01), None
patent: 0189774 (1986-01-01), None
patent: 1308438 (2003-05-01), None
patent: 1318140 (2003-06-01), None
patent: 919073 (1960-09-01), None
patent: WO 91/17748 (1991-11-01), None
patent: WO 96/34851 (1996-11-01), None
patent: WO 97/09315 (1997-03-01), None
patent: WO 97/24343 (1997-07-01), None
patent: WO 98/06691 (1998-02-01), None
patent: WO 98/27108 (1998-06-01), None
patent: WO 99/44987 (1999-09-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 01/055107 (2001-08-01), None
patent: WO 02/49993 (2002-06-01), None
patent: WO 03/037847 (2003-05-01), None
patent: WO 04/020414 (2004-03-01), None
Katritzky et al., Biorg. Med. Chem. Letters (2002), vol. 12, No. 14, pp. 1809-1811.
Clayden et al., Organ. Letters (2000), vol. 2, No. 26, pp. 4229-4232.
Potapov et al., Zhurnal Obshchei Khimii (1962), vol. 32, pp. 1187-1191.
Arumugam et al. (2002)Journal of Surgical Research103:260-67.
Clayden et al., “Dearomatizing Anionic Cyclization of Substituted N-Cumyl-N-benzyl-benzamides on Treatment with LDA: Synthesis of Partially Saturated Substituted Isoindolones,” Organic Letters 2(26):4229-4232 (2000).
Ahmed et al., “Synthesis of a potent (+)-4-(2-hydroxphenyl) analogue of the acromelic acids by dearomatising cyclisation of a lithiated N-p-methoxybenzyl-4-methoxy-1-napthamide,” Tetrahedron Letters 42:3407-3410 (2001).
Allen et al., “Dendroids: a building block for the synthesis of polymodal dendritic strutures,” Chem. Commun., 2121-2122 (1997).
Database CA on STN, (Columbus, OH, USA), RN 326025-32-5, “(1,1'-Biphenyl]-2-carboxamide, N-[1-(2-furanyl)enthyl]-N-2-pyridinyl-4'-(triflouromethyl),” XP002345343, Abstract, 2001.
Database CA on STN, (Columbus, OH, USA), No. 1957:12940, Nakajima et al., “Preparation of 3-phenylsalicylamide derivatives,” XP002345344, Yakugaku Zasshi, vol. 76, pp. 1211-1213 (1956).
Database CA on STN, (Columbus, OH, USA), RN 336149-76-9, “[1,1'Biphenyl]-4-carboxamide, N-[(3-methyl-2-thienyl)mehtyl]-N-(phenylmethyl),” XP002345795, Abstract, 2001.
Database CA on STN, (Columbus, OH, USA), RN 302590-68-7, “[1,1'Biphenyl]-4-carboxamide, N-(2-phenlcyclopropyl)-N-(phenylmethyl),” XP002345796, Abstract, 2000.
Database CA on STN, (Columbus, OH, USA), RN 304510-82-5, “[1,1'Biphenyl]-4-carboxamide, N,N-bis(phenylmethyl),” XP002345797, Abstract, 2000.
Database CA on STN, (Columbus, OH, USA), RN 339236-92-9, “[1,1'-Biphenyl]-4-carboxamide, N-[2-(2,4-dichloropheynyl)ethyl]-N-[(2-fluorophenyl)methyl], ” XP002345798, Abstract, 2001.
Database CA on STN, (Columbus, OH, USA), RN 335639-67-3, “[1,1'-Biphenyl]-4-carboxamide, N-(2-furanylmethyl)-N-(4pyridinylmethyl),” XP002345799, Abstract, 2001.
Database CA on STN, (Columbus, OH, USA), RN 335254-50-7, “[1,1'-Biphenyl]-4-carboxamide, N-](3-methyl-2-thienyl)methyl]-N-(1,2,3,4-tetrahydro-1-naphthalenyl),” XP002345800, Abstract, 2001.
Gao Yang
Hutchinson Alan J.
Pringle Wallace C.
Yoon Taeyoung
Zhao He
Fidel Seth A.
Kadlecek Ann T.
Neurogen Corporation
Solola Taofiq
LandOfFree
Substituted biaryl amides as C5A receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted biaryl amides as C5A receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted biaryl amides as C5A receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3671919